DK1507519T3 - Lægemiddel med forsinket frigivelse af det aktive middel 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methylpentan-3-ol - Google Patents

Lægemiddel med forsinket frigivelse af det aktive middel 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methylpentan-3-ol

Info

Publication number
DK1507519T3
DK1507519T3 DK03732464T DK03732464T DK1507519T3 DK 1507519 T3 DK1507519 T3 DK 1507519T3 DK 03732464 T DK03732464 T DK 03732464T DK 03732464 T DK03732464 T DK 03732464T DK 1507519 T3 DK1507519 T3 DK 1507519T3
Authority
DK
Denmark
Prior art keywords
methylpentan
methoxyphenyl
dimethylamino
delayed
active agent
Prior art date
Application number
DK03732464T
Other languages
Danish (da)
English (en)
Inventor
Iris Ziegler
Johannes Bartholomaeus
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1507519T3 publication Critical patent/DK1507519T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK03732464T 2002-05-29 2003-05-26 Lægemiddel med forsinket frigivelse af det aktive middel 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methylpentan-3-ol DK1507519T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224108A DE10224108A1 (de) 2002-05-29 2002-05-29 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
DK1507519T3 true DK1507519T3 (da) 2006-08-28

Family

ID=29557413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03732464T DK1507519T3 (da) 2002-05-29 2003-05-26 Lægemiddel med forsinket frigivelse af det aktive middel 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methylpentan-3-ol

Country Status (14)

Country Link
EP (1) EP1507519B1 (es)
JP (1) JP5459818B2 (es)
AR (1) AR039900A1 (es)
AT (1) ATE326218T1 (es)
AU (1) AU2003238397A1 (es)
CA (1) CA2488220C (es)
DE (2) DE10224108A1 (es)
DK (1) DK1507519T3 (es)
ES (1) ES2263976T3 (es)
MY (1) MY134311A (es)
PE (1) PE20040529A1 (es)
PL (1) PL218397B1 (es)
PT (1) PT1507519E (es)
WO (1) WO2003099267A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH06172161A (ja) * 1992-12-10 1994-06-21 Shin Etsu Chem Co Ltd 徐放性錠剤
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JPH1017497A (ja) * 1996-07-02 1998-01-20 Takeda Chem Ind Ltd 徐放性製剤およびその製造方法
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
PL374186A1 (en) 2005-10-03
JP2005534640A (ja) 2005-11-17
AR039900A1 (es) 2005-03-09
MY134311A (en) 2007-12-31
PL218397B1 (pl) 2014-11-28
PE20040529A1 (es) 2004-08-24
CA2488220A1 (en) 2003-12-04
ATE326218T1 (de) 2006-06-15
ES2263976T3 (es) 2006-12-16
DE50303372D1 (de) 2006-06-22
JP5459818B2 (ja) 2014-04-02
AU2003238397A1 (en) 2003-12-12
WO2003099267A1 (de) 2003-12-04
DE10224108A1 (de) 2004-01-29
PT1507519E (pt) 2006-08-31
EP1507519B1 (de) 2006-05-17
EP1507519A1 (de) 2005-02-23
CA2488220C (en) 2011-02-01

Similar Documents

Publication Publication Date Title
ATE380544T1 (de) Umhüllte feste darreichungsform
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
DK1439829T3 (da) Lægemiddel indeholdende 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol med forsinket frigivelse af det aktive stof
DK1681932T3 (da) Herbicidt aktivt middel
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1399444T3 (da) Nye heterocycliske forbindelser, fremgangsmåde til fremstilling af samme samt anvendelse deraf som lægemidler, især som antibakterielle midler
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
DE50309032D1 (de) Fungizide wirkstoffkombinationen
ATE392813T1 (de) Fungizide wirkstoffkombination
ITRM20020133V0 (it) Complesso di elementi per l'assiemaggio di strutture.
DK1551860T3 (da) Glukokortikoid-receptorligander til behandling af stofskifteforstyrrelser
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
IS8327A (is) Módafíníl breyttar losaðar lyfjasamsetningar
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
DK1795186T3 (da) Flupirtinomfattende lægemiddelformulering med en kontrolleret frisætning af det aktive middel
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
DK1478366T3 (da) Farmaceutiske kombinationer af meloxicam, codeinphosphat og paracetamol
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
DE50304722D1 (de) Fungizide Wirkstoffkombinationen
DK1541137T3 (da) Transdermalt delivery system af gestoden
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme